Cargando…
Dectin-1 Signaling Update: New Perspectives for Trained Immunity
The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses. However, over time, different ligands both of microbial-derived and endogenous origin have been shown to be recognized by Dectin-1. The ou...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882614/ https://www.ncbi.nlm.nih.gov/pubmed/35237264 http://dx.doi.org/10.3389/fimmu.2022.812148 |
_version_ | 1784659733256339456 |
---|---|
author | Mata-Martínez, Pablo Bergón-Gutiérrez, Marta del Fresno, Carlos |
author_facet | Mata-Martínez, Pablo Bergón-Gutiérrez, Marta del Fresno, Carlos |
author_sort | Mata-Martínez, Pablo |
collection | PubMed |
description | The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses. However, over time, different ligands both of microbial-derived and endogenous origin have been shown to be recognized by Dectin-1. The outcomes of this recognition are diverse, including pro-inflammatory responses such as cytokine production, reactive oxygen species generation and phagocytosis. Nonetheless, tolerant responses have been also attributed to Dectin-1, depending on the specific ligand engaged. Dectin-1 recognition of their ligands triggers a plethora of downstream signaling pathways, with complex interrelationships. These signaling routes can be modulated by diverse factors such as phosphatases or tetraspanins, resulting either in pro-inflammatory or regulatory responses. Since its first depiction, Dectin-1 has recently gained a renewed attention due to its role in the induction of trained immunity. This process of long-term memory of innate immune cells can be triggered by β-glucans, and Dectin-1 is crucial for its initiation. The main signaling pathways involved in this process have been described, although the understanding of the above-mentioned complexity in the β-glucan-induced trained immunity is still scarce. In here, we have reviewed and updated all these factors related to the biology of Dectin-1, highlighting the gaps that deserve further research. We believe on the relevance to fully understand how this receptor works, and therefore, how we could harness it in different pathological conditions as diverse as fungal infections, autoimmunity, or cancer. |
format | Online Article Text |
id | pubmed-8882614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88826142022-03-01 Dectin-1 Signaling Update: New Perspectives for Trained Immunity Mata-Martínez, Pablo Bergón-Gutiérrez, Marta del Fresno, Carlos Front Immunol Immunology The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses. However, over time, different ligands both of microbial-derived and endogenous origin have been shown to be recognized by Dectin-1. The outcomes of this recognition are diverse, including pro-inflammatory responses such as cytokine production, reactive oxygen species generation and phagocytosis. Nonetheless, tolerant responses have been also attributed to Dectin-1, depending on the specific ligand engaged. Dectin-1 recognition of their ligands triggers a plethora of downstream signaling pathways, with complex interrelationships. These signaling routes can be modulated by diverse factors such as phosphatases or tetraspanins, resulting either in pro-inflammatory or regulatory responses. Since its first depiction, Dectin-1 has recently gained a renewed attention due to its role in the induction of trained immunity. This process of long-term memory of innate immune cells can be triggered by β-glucans, and Dectin-1 is crucial for its initiation. The main signaling pathways involved in this process have been described, although the understanding of the above-mentioned complexity in the β-glucan-induced trained immunity is still scarce. In here, we have reviewed and updated all these factors related to the biology of Dectin-1, highlighting the gaps that deserve further research. We believe on the relevance to fully understand how this receptor works, and therefore, how we could harness it in different pathological conditions as diverse as fungal infections, autoimmunity, or cancer. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8882614/ /pubmed/35237264 http://dx.doi.org/10.3389/fimmu.2022.812148 Text en Copyright © 2022 Mata-Martínez, Bergón-Gutiérrez and del Fresno https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Mata-Martínez, Pablo Bergón-Gutiérrez, Marta del Fresno, Carlos Dectin-1 Signaling Update: New Perspectives for Trained Immunity |
title | Dectin-1 Signaling Update: New Perspectives for Trained Immunity |
title_full | Dectin-1 Signaling Update: New Perspectives for Trained Immunity |
title_fullStr | Dectin-1 Signaling Update: New Perspectives for Trained Immunity |
title_full_unstemmed | Dectin-1 Signaling Update: New Perspectives for Trained Immunity |
title_short | Dectin-1 Signaling Update: New Perspectives for Trained Immunity |
title_sort | dectin-1 signaling update: new perspectives for trained immunity |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882614/ https://www.ncbi.nlm.nih.gov/pubmed/35237264 http://dx.doi.org/10.3389/fimmu.2022.812148 |
work_keys_str_mv | AT matamartinezpablo dectin1signalingupdatenewperspectivesfortrainedimmunity AT bergongutierrezmarta dectin1signalingupdatenewperspectivesfortrainedimmunity AT delfresnocarlos dectin1signalingupdatenewperspectivesfortrainedimmunity |